Analyses for abnormality of cell cycle regulator molecules and their application to diagnosis and therapy in bone and soft tissue tumors
细胞周期调节分子异常分析及其在骨和软组织肿瘤诊断和治疗中的应用
基本信息
- 批准号:14570161
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have previously reported several diverse functions of cell cycle regulator molecules. In this research project, more detailed analysis was performed using cultured cells as well as human surgical materials of osteosarcoma in comparison to those of lung carcinomas. And, we clarified the followings.i) Overexpression of cyclin D1 or ccdk4, which cause apoptosis in neuronal cultured cells, also caused apoptosis in osteosarcoma and in other cultured cells (Anticancer Res. 2003, Curr. Medic. Chem. 2003).ii) Furthermore, apoptosis induced by overexpression of cyclin D1/cdk4 was observed in human tumors, such as lung carcinomas (Int. J. Cancer 2004).iii) The protein levels of cyclins/cdks were diversely regulated not only by their expression, but also by degradation system, depending on the histological types. In lung carcinoma, cyclin A is highly expressed in proliferating cells and rapidly degraded. However, cyclin E, specifically in squamous cell carcinoma, is accumulated as kinase-inactive-form without degradation in proteasome system (J. Pathol. 2003).iv) Epidermal growth factor receptor (EGFR) is overexpressed in 7 to 15% of the cases in carcinomas of gastrointestinal tract, and overexpression is predominantly caused by gene amplification (Mod. Pathol. 2004).v) Overexpression of EGFR was observed in 2% of bone and soft tissue sarcomas, and those cases were exclusively associated with gene abnormality, i.e., amplification and polysomy (manuscript submitted).
我们以前曾报道过几种不同的细胞周期调节分子的功能。在本研究项目中,使用培养的细胞以及骨肉瘤的人类手术材料进行了更详细的分析,并与肺癌进行了比较。i)引起神经元培养细胞凋亡的细胞周期蛋白D1或ccdk 4的过表达也引起骨肉瘤和其它培养细胞的凋亡(Anticancer Res.2003,Curr.医生ii)此外,在人肿瘤如肺癌中观察到由细胞周期蛋白D1/cdk 4的过表达诱导的细胞凋亡(Int. J. Cancer 2004)。iii)细胞周期蛋白/cdk的蛋白质水平不仅通过其表达,而且通过降解系统,取决于组织学类型,受到不同程度的调节。在肺癌中,细胞周期蛋白A在增殖细胞中高度表达并迅速降解。然而,细胞周期蛋白E,特别是在鳞状细胞癌中,在蛋白酶体系统中以激酶失活形式积累而不降解(J. Pathol. iv)表皮生长因子受体(EGFR)在7 - 15%的胃肠道癌病例中过表达,并且过表达主要由基因扩增引起(Mod.Pathol.2003)。v)在2%的骨和软组织肉瘤中观察到EGFR的过表达,并且这些病例仅与基因异常相关,即,扩增和多体性(手稿提交)。
项目成果
期刊论文数量(38)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dobashi, Y., et al.: "Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas."Journal of Pathology. 199(2). 208-220 (2003)
Dobashi, Y. 等人:“人原发性肺癌中 G1/S 细胞周期蛋白的表达多样性及其预后意义。”病理学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Dobashi, Y., et al.: "Overexpression of Cdk4/Cyclin D1, a possible mediator of apoptosis and an indicator of prognosis in human primary lung Carcinomas."International Journal of Cancer. (In press).
Dobashi, Y. 等人:“Cdk4/Cyclin D1 的过度表达,可能是细胞凋亡的介质,也是人原发性肺癌预后的指标。”国际癌症杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sakurai, H, Dobashi, Y, Mizutani, E, Matsubara, H., Suzuki, S, Takano, K, Shindo, S, Matsumoto, M.: "Bronchioloalveolar carcinoma of the lung 3 cm or less in diameter : A prognostic assessment."Ann Thorac Surg. (In Press).
Sakurai, H, Dobashi, Y, Mizutani, E, Matsubara, H., Suzuki, S, Takano, K, Shindo, S, Matsumoto, M.:“直径 3 厘米或以下的细支气管肺泡癌:预后评估
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Dobashi, Y., et al.: "Overexpression of Cdk4/Cyclin D1, a possible mediator of apoptosis and an indicator of prognosis in human primary lung Carcinomas."International Journal of Cancer. 110(4). 532-541 (2004)
Dobashi, Y. 等人:“Cdk4/Cyclin D1 的过度表达,可能是细胞凋亡的介质,也是人原发性肺癌预后的指标。”国际癌症杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Dobashi, Y., et al.: "Perspectives for Cancer Therapy : "Cell Cycle Blockers and Perturbators""Current Medicinal Chemistry. (In press).
Dobashi, Y. 等人:“癌症治疗的展望:“细胞周期阻断剂和扰动剂”“当前药物化学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOBASHI Yoh其他文献
DOBASHI Yoh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOBASHI Yoh', 18)}}的其他基金
Involvement of Akt/mTOR in lung cancer and design of novel therapy targeting them
Akt/mTOR 与肺癌的关系及其新疗法的设计
- 批准号:
26460438 - 财政年份:2014
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Aberrant activations of cellular kinases and exploration of novel targeted therapy in human solid cancers
细胞激酶的异常激活和人类实体癌新型靶向治疗的探索
- 批准号:
23590409 - 财政年份:2011
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Activation of signal transduction pathway by aberration of oncogenes : comprehensive analysis and application for multi-molecular targeting therapy
癌基因畸变激活信号转导通路:多分子靶向治疗的综合分析与应用
- 批准号:
20590351 - 财政年份:2008
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Aberrant activation of signal transduction pathways regulating cell proliieration in human slid tumors. Molecular-pathological analysis and clinical application of molecular targeting therapy.
调节人类肿瘤细胞增殖的信号转导途径的异常激活。
- 批准号:
18590327 - 财政年份:2006
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of abnomatily of cell cycle regulation and its clinical application in human lung cancer
人肺癌细胞周期调控异常及其临床应用研究
- 批准号:
11670191 - 财政年份:1999
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
The role of the RO60 (TROVE2) autoantigen in modulating cell-cycle progression, apoptosis and chemo-resistance in cancer cells
RO60 (TROVE2) 自身抗原在调节癌细胞的细胞周期进程、细胞凋亡和化疗耐药中的作用
- 批准号:
234333147 - 财政年份:2013
- 资助金额:
$ 2.24万 - 项目类别:
Research Grants
Downregulation o fserine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells
富含丝氨酸/精氨酸的剪接因子 3 的下调诱导结肠癌细胞 G1 细胞周期停滞和凋亡
- 批准号:
23590943 - 财政年份:2011
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Cellular Stress Response in Cold-adapted Organisms: Building Novel Mechanistic Links between Heat Stress, Cell Cycle Arrest and Apoptosis in Antarctic Fishes.
适应寒冷的生物体的细胞应激反应:在南极鱼类的热应激、细胞周期停滞和细胞凋亡之间建立新的机制联系。
- 批准号:
0944743 - 财政年份:2010
- 资助金额:
$ 2.24万 - 项目类别:
Standard Grant
Cell cycle and apoptosis analysis of synergistic and antagonistic anti-cancer drug conbinations
协同和拮抗抗癌药物组合的细胞周期和凋亡分析
- 批准号:
358574-2007 - 财政年份:2009
- 资助金额:
$ 2.24万 - 项目类别:
Industrial Research Fellowships
DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk
DNA 修复、细胞周期检查点和细胞凋亡以及膀胱癌风险
- 批准号:
8065522 - 财政年份:2009
- 资助金额:
$ 2.24万 - 项目类别:
DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk
DNA 修复、细胞周期检查点和细胞凋亡以及膀胱癌风险
- 批准号:
7661914 - 财政年份:2009
- 资助金额:
$ 2.24万 - 项目类别:
DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk
DNA 修复、细胞周期检查点和细胞凋亡以及膀胱癌风险
- 批准号:
8268502 - 财政年份:2009
- 资助金额:
$ 2.24万 - 项目类别:
DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk
DNA 修复、细胞周期检查点和细胞凋亡以及膀胱癌风险
- 批准号:
7848344 - 财政年份:2009
- 资助金额:
$ 2.24万 - 项目类别:
Cell Cycle/Apoptosis Gene Variants and Breast Cancer Risk
细胞周期/凋亡基因变异和乳腺癌风险
- 批准号:
8075439 - 财政年份:2008
- 资助金额:
$ 2.24万 - 项目类别: